Cargando…
Effects of 1α,25-dihydroxyvitamin D(3) on the pharmacokinetics and biodistribution of ergothioneine, an endogenous organic cation/carnitine transporter 1 substrate, in rats
PURPOSE: This study aimed to investigate the effects of 1α,25-dihydroxyvitamin D(3) (1,25(OH)(2)D(3)) on the expression levels of organic cation/carnitine transporter 1 (OCTN1) as well as the pharmacokinetics and biodistribution of ergothioneine, an OCTN1 substrate, in rats. METHODS: Rats pretreated...
Autores principales: | Vo, Dang-Khoa, Nguyen, Thi-Thao-Linh, Maeng, Han-Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911105/ https://www.ncbi.nlm.nih.gov/pubmed/35291466 http://dx.doi.org/10.1007/s40005-022-00563-1 |
Ejemplares similares
-
Differential Effects of 1α,25-Dihydroxyvitamin D(3) on the Expressions and Functions of Hepatic CYP and UGT Enzymes and Its Pharmacokinetic Consequences In Vivo
por: Doan, Trang Nguyen Kieu, et al.
Publicado: (2020) -
Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
por: Nguyen, Thi-Thao-Linh, et al.
Publicado: (2021) -
Effects of 1α,25-Dihydroxyvitamin D(3) on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in Rats with PBPK Modeling Approach
por: Balla, Anusha, et al.
Publicado: (2021) -
Oxidized Forms of Ergothioneine Are Substrates for Mammalian Thioredoxin Reductase
por: Jenny, Kaelyn A., et al.
Publicado: (2022) -
Pharmacokinetics and Pharmacodynamics of Intranasal Solid Lipid Nanoparticles and Nanostructured Lipid Carriers for Nose-to-Brain Delivery
por: Nguyen, Thi-Thao-Linh, et al.
Publicado: (2022)